Kneu Health Joins Cedars-Sinai Accelerator to Revolutionise Parkinson's Disease and Dementia in the US

Kneu Health, a leading digital neurology care platform, is excited to announce its acceptance into the Cedars-Sinai Accelerator program in Los Angeles. This achievement marks a significant milestone for Kneu Health as it continues to drive innovation in Parkinson's Disease and Dementia care. Kneu Health was founded based on 10+ years of research at Oxford University and currently serves patients across hospitals in the NHS. John Glaser, Board Chairman of Kneu Health said, "There is a significant need to improve the care of people with Dementia and Parkinson's in the US, conditions affecting over 10 million people including members of my family. The Cedars program is a very important step in Kneu Health's introduction of its technology and services to America."

The Cedars-Sinai Accelerator, known for fostering groundbreaking advancements in medical technology, will provide Kneu Health with unparalleled resources and mentorship to accelerate its growth. This program is designed to support startups that are transforming healthcare through cutting-edge solutions, and Kneu Health's inclusion is a testament to its potential to impact the industry positively.

Kneu Health is dedicated to enhancing patient care through its state-of-the-art digital health platform, which leverages patient assessments and artificial intelligence to offer personalized and actionable health insights. The solution provides patients with educational resources to ensure symptom management and medication adherence as they go through their care journey while connecting the entire care team. The company's innovative approach improves health outcomes and streamlines the patient experience.

"We are honored and excited to join the Cedars-Sinai Accelerator program," said Caroline Cake, CEO and Founder of Kneu Health. "This opportunity aligns perfectly with our mission to revolutionize neurology care through technology. The support and expertise from Cedars-Sinai will be invaluable as we advance our platform and expand our impact for patients." For more information about Kneu Health and its participation in the Cedars-Sinai Accelerator program, please visit: https://www.cedars-sinai.org/newsroom/cedars-sinai-accelerator-welcomes-10th-class-of-health-tech-startups/

About Kneu Health

Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.